ATLAS (AltaValve) Pivotal Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.

Also called NCT06465745

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 450 participants (planned count) (from the registry)
Sponsor
4C Medical Technologies, Inc. (from the registry)
Registry
  • NCT NCT06465745
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada, France, Germany, Greece, Poland, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06465745. Non-randomized; no masking; primary purpose treatment. Start 2024-09-03 (actual); primary completion 2029-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ATLAS (AltaValve) Pivotal Trial
Acronym
ATLAS
Condition
Mitral Regurgitation
Condition
Mitral Insufficiency
Condition
Mitral Valve Incompetence
Condition
Mitral Valve Regurgitation
Condition
Mitral Incompetence
Intervention (Device)
AltaValve System.
Lead sponsor
4C Medical Technologies, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06465745
Content hash
f23621b29f94e2d840e4cbe870a06a35367938ecb22466d2d26cbead028ccb05